Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies.
The Boehringer Ingelheim group of companies' objectives and beliefs can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision.
Research & Development
Our new discovery research strategy aims at enhancing our capacity for innovation and at encouraging scientific creativity for diseases with high unmet medical need.
How We Discover
From initial discovery to a marketable medicine is a long, challenging road. It takes about 12 - 15 years from discovery to the approved medication and requires an investment of about US $1 billion.
Working at Boehringer Ingelheim – Being part of a global family
As a research-driven pharmaceutical company Boehringer Ingelheim strives to improve health of people and animals everywhere in the world.
25 May 2016 at 09:00
Boehringer Ingelheim increases access to the medication for the treatment of HIV/Aids
BOEHRINGER INGELHEIM 12 May 2016 at 11:01
We are live at the The European Stroke Organisation Conference in sunny Barcelona! We're excited to be here with Jon Barrick, President of the Stroke Alliance for Europe, to discuss his views on the first results of our AF patient survey.
Boehringer Ingelheim takes responsibility for nature and the climate. Read more and find out how this generates greater efficiency and innovative products.
11 May 2016 at 09:00
Nine out of 10 AF patients are concerned about stroke and many want to be part of OAC treatment decisions, new international survey shows
Making More Health
Our global MMH initiative identifies and supports innovative health solutions by focusing on social entrepreneurial activities and co-creation
Ask questions, get answers, receive tips, welcome to the Boehringer Ingelheim career blog